Proteolysis-targeting chimeras (PROTACs) have redefined the paradigm of targeted protein degradation by hijacking the endogenous ubiquitin-proteasome system. However, their clinical translation remains hampered by "beyond-rule-of-five" (bRo5) physicochemical... ...

请注册登录后继续浏览